---
title: "Bionano Genomics (BNGO.US) — 财务报表"
type: "Symbol"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/quote/BNGO.US/norm.md"
symbol: "BNGO.US"
name: "Bionano Genomics"
parent: "https://longbridge.com/zh-CN/quote/BNGO.US.md"
datetime: "2026-05-21T21:47:40.582Z"
locales:
  - [en](https://longbridge.com/en/quote/BNGO.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/BNGO.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/BNGO.US/norm.md)
---

# Bionano Genomics (BNGO.US) — 财务报表

## 利润表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 每股收益 | -0.7600 | -0.7707 | -1.59 | -1.99 | -1.15 |
| ROE | -81.12% | -67.35% | -71.47% | -58.63% | -29.70% |
| 营业收入 | 6.69M | 7.95M | 7.37M | 6.73M | 6.46M |
| 净利润 | -8.30M | -7.93M | -8.50M | -6.86M | -3.10M |
| 营业利润 | -7.90M | -8.54M | -8.54M | -7.80M | -8.46M |
| 毛利率 | 48.63% | 42.75% | 45.74% | 51.64% | 45.50% |
| 净利率 | -124.17% | -99.77% | -115.42% | -101.84% | -48.04% |
| 利润含金量 | - | - | - | - | - |

## 资产负债表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 资产与负债 | 64.80M | 73.58M | 79.06M | 76.01M | 78.41M |
| 权益乘数 | 1.73 | 1.66 | 1.59 | 1.68 | 1.63 |
| 每股净资产 | 3.32 | 4.14 | 5.12 | 11.61 | 15.54 |
| 资产周转率 | 0.4013 | 0.3795 | 0.3451 | 0.2671 | 0.2408 |
| 现金及短投 | 14.40M | 19.27M | 21.58M | 16.44M | 18.23M |
| 存货与应收 | 5.31M | 5.45M | 7.05M | 8.63M | 9.56M |
| 长期投资 | 20.15M | 21.16M | 22.82M | 24.23M | 22.70M |
| 净债务 | 2.61M | -2.38M | -4.39M | 3.14M | 184000.00 |

## 现金流量表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 经营现金流 | -5.72M | -4.17M | -5.92M | -3.49M | -2.76M |
| 投资现金流 | 5.46M | 4.01M | -4.67M | 1.98M | -14.07M |
| 融资现金流 | 657000.00 | 1.60M | 10.08M | 1.47M | 10.89M |
| 自由现金流 | -2.86M | -778000.00 | -1.90M | -1.59M | -114625.00 |
| 现金流充裕率 | -28580.00% | -23194.44% | -312.51% | -229.71% | -182.32% |
| 举债与偿债 | - | - | - | - | - |
| 资本支出 | - | - | - | - | - |